keyword
https://read.qxmd.com/read/38625552/neuroprotective-effects-of-chlorogenic-acid-against-oxidative-stress-in-rats-subjected-to-lithium-pilocarpine-induced-status-epilepticus
#1
JOURNAL ARTICLE
Alberth Jonnathan Carreño-González, José Luiz Liberato, Marcus Vinicius Batista Celani, Norberto Peporine Lopes, João Luís Callegari Lopes, Leonardo Gobbo-Neto, Andreia Cristina Karklin Fontana, Wagner Ferreira Dos Santos
Epilepsy is a condition marked by sudden, self-sustained, and recurring brain events, showcasing unique electro-clinical and neuropathological phenomena that can alter the structure and functioning of the brain, resulting in diverse manifestations. Antiepileptic drugs (AEDs) can be very effective in 30% of patients in controlling seizures. Several factors contribute to this: drug resistance, individual variability, side effects, complexity of epilepsy, incomplete understanding, comorbidities, drug interactions, and no adherence to treatment...
April 16, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38613879/using-scalp-eeg-to-predict-seizure-recurrence-and-electrical-status-epilepticus-in-children-with-idiopathic-focal-epilepsy
#2
JOURNAL ARTICLE
Xiaofei Ye, Panpan Hu, Bin Yang, Yang Yang, Ding Gao, Ginger Qinghong Zeng, Kai Wang
PURPOSE: Some individuals with idiopathic focal epilepsy (IFE) experience recurring seizures accompanied by the evolution of electrical status epilepticus during sleep (ESES). Here, we aimed to develop a predictor for the early detection of seizure recurrence with ESES in children with IFE using resting state electroencephalogram (EEG) data. METHODS: The study group included 15 IFE patients who developed seizure recurrence with ESES. There were 17 children in the control group who did not experience seizure recurrence with ESES during at least 2-year follow-up...
March 27, 2024: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/38610222/comparative-outcomes-of-levetiracetam-and-phenobarbital-usage-in-the-treatment-of-neonatal-seizures-a-retrospective-analysis
#3
JOURNAL ARTICLE
Handan Hakyemez Toptan, Nazmiye Nilgun Karadag, Sevilay Topcuoglu, Elif Ozalkaya, Emre Dincer, Hakan Cakir, Asli Okbay Gunes, Guner Karatekin
OBJECTIVES AND AIM: The primary aim of this study was to conduct a comparative analysis of the safety and efficacy of levetiracetam (LEV) and phenobarbital (PB) as first-line treatments for neonatal seizure management. This study was designed to measure and compare the incidence of adverse effects and to determine the discharge and mortality rates associated with the use of these antiseizure medications (ASMs). Through this comparison, this research sought to provide insights to optimise care for neonates experiencing seizures...
April 7, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38608741/early-treatment-with-rifaximin-during-epileptogenesis-reverses-gut-alterations-and-reduces-seizure-duration-in-a-mouse-model-of-acquired-epilepsy
#4
JOURNAL ARTICLE
Valentina Kebede, Teresa Ravizza, Silvia Balosso, Rossella Di Sapia, Luca Canali, Sara Soldi, Serena Galletti, Christina Papazlatani, Panagiotis A Karas, Sotirios Vasileiadis, Annalisa Sforzini, Laura Pasetto, Valentina Bonetto, Annamaria Vezzani, Loredana Vesci
The gut microbiota is altered in epilepsy and is emerging as a potential target for new therapies. We studied the effects of rifaximin, a gastrointestinal tract-specific antibiotic, on seizures and neuropathology and on alterations in the gut and its microbiota in a mouse model of temporal lobe epilepsy (TLE). Epilepsy was induced by intra-amygdala kainate injection causing status epilepticus (SE) in C57Bl6 adult male mice. Sham mice were injected with vehicle. Two cohorts of SE mice were fed a rifaximin-supplemented diet for 21 days, starting either at 24 h post-SE (early disease stage) or at day 51 post-SE (chronic disease stage)...
April 10, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38606469/clinical-practice-guidelines-on-the-management-of-status-epilepticus-in-adults-a-systematic-review
#5
REVIEW
Luca Vignatelli, Valentina Tontini, Stefano Meletti, Maria Camerlingo, Stefania Mazzoni, Giada Giovannini, Elena Pasini, Roberto Michelucci, Francesca Bisulli, Paolo Tinuper, Lidia Di Vito
OBJECTIVE: Status epilepticus (SE) is the second most common neurological emergency in adults. Despite improvements in the management of acute neurological conditions over the last decade, mortality is still durably high. Because a gap has emerged between SE management based on clinical practice guidelines (CPGs) and actual clinical practice, we conducted a systematic review of CPGs, assessing their quality, outlining commonalities and discrepancies in recommendations, and highlighting research gaps...
April 12, 2024: Epilepsia
https://read.qxmd.com/read/38602656/investigating-the-effects-of-perampanel-on-autophagy-mediated-regulation-of-glua2-and-psd95-in-epilepsy
#6
JOURNAL ARTICLE
Dan Li, Na Sun, Yingying Guo, Shaoping Huang, Chunyan Yin, Yanfeng Xiao, Weijun Ma
Epilepsy is a chronic neurological disorder characterized by recurrent seizures. Despite various treatment approaches, a significant number of patients continue to experience uncontrolled seizures, leading to refractory epilepsy. The emergence of novel anti-epileptic drugs, such as perampanel (PER), has provided promising options for effective epilepsy treatment. However, the specific mechanisms underlying the therapeutic effects of PER remain unclear. This study aimed to investigate the intrinsic molecular regulatory mechanisms involved in the downregulation of GluA2, a key subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, following epileptic seizures...
April 11, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38580802/efficacy-and-tolerability-of-intranasal-midazolam-administration-for-antiseizure-treatment-in-adults-a-systematic-review
#7
REVIEW
Tolga D Dittrich, Dominik Vock, Urs Fisch, Lisa Hert, Sira M Baumann, Paulina S C Kliem, Stephan Rüegg, Stephan Marsch, Gian Marco De Marchis, Raoul Sutter
OBJECTIVE: The objective of this study was to assess the efficacy and tolerability of intranasal midazolam (in-MDZ) administration for antiseizure treatment in adults. METHODS: Embase and Medline literature databases were searched. We included randomized trials and cohort studies (excluding case series) of adult patients (≥ 18 years of age) examining in-MDZ administration for epilepsy, epileptic seizures, or status epilepticus published in English between 1985 and 2022...
April 5, 2024: Neurocritical Care
https://read.qxmd.com/read/38580318/status-epilepticus-an-update-on-pharmacological-management
#8
JOURNAL ARTICLE
Sulaiman Almohaish, Eljim P Tesoro, Gretchen M Brophy
Status epilepticus (SE) is a neurological emergency that requires timely pharmacological therapy to cease seizure activity. The treatment approach varies based on the time and the treatment stage of SE. Benzodiazepines are considered the first-line therapy during the emergent treatment phase of SE. Antiseizure medicines such as phenytoin, valproic acid, and levetiracetam are recommended during the urgent treatment phase. These drugs appear to have a similar safety and efficacy profile, and individualized therapy should be chosen based on patient characteristics...
April 5, 2024: Seminars in Neurology
https://read.qxmd.com/read/38570823/status-epilepticus-in-patients-with-brain-tumors-and-metastases-a-multicenter-cohort-study-of-208-patients-and-literature-review
#9
JOURNAL ARTICLE
Johanna K Rickel, Daria Zeeb, Susanne Knake, Hans Urban, Jürgen Konczalla, Katharina J Weber, Pia S Zeiner, Axel Pagenstecher, Elke Hattingen, André Kemmling, Emmanouil Fokas, Sebastian Adeberg, Robert Wolff, Martin Sebastian, Tillmann Rusch, Michael W Ronellenfitsch, Katja Menzler, Lena Habermehl, Leona Möller, Marcus Czabanka, Christopher Nimsky, Lars Timmermann, Christian Grefkes, Joachim P Steinbach, Felix Rosenow, Leena Kämppi, Adam Strzelczyk
OBJECTIVE: Brain tumors and metastases account for approximately 10% of all status epilepticus (SE) cases. This study described the clinical characteristics, treatment, and short- and long-term outcomes of this population. METHODS: This retrospective, multi-center cohort study analyzed all brain tumor patients treated for SE at the university hospitals of Frankfurt and Marburg between 2011 and 2017. RESULTS: The 208 patients (mean 61.5 ± 14...
April 4, 2024: Neurological research and practice
https://read.qxmd.com/read/38570067/exploring-the-effect-of-6-bio-and-sulindac-in-modulation-of-wnt-%C3%AE-catenin-signaling-pathway-in-chronic-phase-of-temporal-lobe-epilepsy
#10
JOURNAL ARTICLE
Vipasha Gautam, Kajal Rawat, Arushi Sandhu, Anil Kumar, Parampreet Singh Kharbanda, Bikash Medhi, Alka Bhatia, Lekha Saha
The prospective involvement of the Wnt/β-catenin signaling pathway in epilepsy, with the proposed therapeutic uses of its modulators, has been suggested; however, comprehensive knowledge in this regard is currently limited. Despite postulations about the pathway's significance and treatment potential, a systematic investigation is required to better understand its implications in chronic epilepsy. We investigated the role of key proteins like β-catenin, GSK-3β, and their modulators sulindac and 6-BIO, in Wnt/β-catenin pathway during chronic phase of temporal lobe epilepsy...
April 1, 2024: Neuropharmacology
https://read.qxmd.com/read/38563451/effect-of-a-declined-plasma-concentration-of-valproic-acid-induced-by-meropenem-on-the-antiepileptic-efficacy-of-valproic-acid
#11
REVIEW
Chunping Gu, Yongfang Zhang, Fumiao Yuan, Kaibin Huang, Zhenzhou Lin, Qiong Chen, Yan Chen, Yongming Wu, Dongmei Wang, Shengnan Wang
OBJECTIVE: This study aimed to indicate whether a declined plasma concentration of valproic acid (VPA) induced by co-administration of meropenem (MEPM) could affect the antiepileptic efficacy of VPA. METHODS: We retrospectively reviewed data of hospitalized patients who were diagnosed with status epilepticus or epilepsy between 2010 and 2019. Patients co-administered VPA and MEPM during hospitalization were screened and assigned to the exposure group, while those co-administerd VPA and other broad-spectrum antibiotics were allocated to the control group...
April 2, 2024: Journal of Clinical Laboratory Analysis
https://read.qxmd.com/read/38560778/potassium-channel-related-epilepsy-pathogenesis-and-clinical-features
#12
REVIEW
Tong Zhao, Le Wang, Fang Chen
Variants in potassium channel-related genes are one of the most important mechanisms underlying abnormal neuronal excitation and disturbances in the cellular resting membrane potential. These variants can cause different forms of epilepsy, which can seriously affect the physical and mental health of patients, especially those with refractory epilepsy or status epilepticus, which are common among pediatric patients and are potentially life-threatening. Variants in potassium ion channel-related genes have been reported in few studies; however, to our knowledge, no systematic review has been published...
April 1, 2024: Epilepsia Open
https://read.qxmd.com/read/38558319/brivaracetam-use-in-clinical-practice-a-delphi-consensus-on-its-role-as-first-add-on-therapy-in-focal-epilepsy-and-beyond
#13
JOURNAL ARTICLE
Simona Lattanzi, Valentina Chiesa, Giancarlo Di Gennaro, Edoardo Ferlazzo, Angelo Labate, Angela La Neve, Stefano Meletti, Carlo Di Bonaventura
BACKGROUND: Antiseizure medications remain the cornerstone of treatment for epilepsy, although a proportion of individuals with the condition will continue to experience seizures despite appropriate therapy. Treatment choices for epilepsy are based on variables related to both the individual patient and the available medications. Brivaracetam is a third-generation agent antiseizure medication. METHODS: We carried out a Delphi consensus exercise to define the role of brivaracetam in clinical practice and to provide guidance about its use as first add-on ASM and in selected clinical scenarios...
April 1, 2024: Neurological Sciences
https://read.qxmd.com/read/38552593/status-epilepticus-after-mechanical-thrombectomy-the-role-of-early-eeg-assessment-in-stroke-unit-clinical-and-radiological-prognostication
#14
JOURNAL ARTICLE
Gabriele Prandin, Giovanni Furlanis, Ilario Scali, Federica Palacino, Laura Mancinelli, Emanuele Vincis, Paola Caruso, Giulia Mazzon, Marinella Tomaselli, Marcello Naccarato, Paolo Manganotti
BACKGROUND: Convulsive (CSE) and non-convulsive (NCSE) Status Epilepticus are a complication in 0.2-0.3% ischemic strokes. Large stroke and cortical involvement are the main risk factors for developing SE. This study evaluates the prevalence of SE in patients treated with endovascular thrombectomy (EVT) through EEG recording within 72- h from admission. Moreover, we compared clinical, radiological, and outcome measures in SE and no-SE patients. MATERIALS AND METHODS: We collected retrospectively demographical and clinical characteristics of acute ischemic stroke patients who underwent EVT, admitted in the Stroke Unit (SU) of the University Hospital of Trieste between January 2018 and March 2020 who underwent EEG recording within 72- h from the symptoms' onset...
March 12, 2024: Epilepsy Research
https://read.qxmd.com/read/38546233/hydrogen-treatment-reduces-electroencephalographic-activity-and-neuronal-death-in-rats-with-refractory-status-epilepticus-by-inhibiting-membrane-nr2b-phosphorylation-and-oxidative-stress
#15
JOURNAL ARTICLE
Ruihua Jia, Gemin Zhu, Rui Zhao, Tian Li, Wen Jiang, Xiaoli Cui
OBJECTIVE: To investigate the effects of hydrogen therapy on epileptic seizures in rats with refractory status epilepticus and the underlying mechanisms. METHODS: Status epilepticus was induced using pilocarpine. The effects of hydrogen treatment on epilepsy severity in model rats were then monitored using Racine scores and electroencephalography (EEG), followed by western blot of plasma membrane N-methyl-D-aspartate receptor subtype 2B (NR2B) and phosphorylated NR2B expression...
March 2024: Journal of International Medical Research
https://read.qxmd.com/read/38545032/risk-factors-of-electrical-status-epilepticus-during-sleep-in-children-with-benign-childhood-epilepsy-with-centro-temporal-spikes
#16
JOURNAL ARTICLE
Xiufeng Wang, Yanling Zhang, Ruixue Sun, Na Kong
OBJECTIVE: To explore risk factors of electrical status epilepticus during sleep in children with benign childhood epilepsy with centro-temporal spikes (BECT). METHODS: This is a clinical comparative study. The subjects of study were 67 children with BECT from the Outpatient Department of Pediatric Neurology in Xingtai People's Hospital from January 2019 to January 2022. According to the occurrence of ESES, the enrolled children were divided into control group which included BECT children without ESES and the observation group which included BECT children with ESES...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38536044/acetazolamide-as-an-effective-treatment-for-pilomotor-seizures-in-autoimmune-encephalitis
#17
JOURNAL ARTICLE
Kia Gilani, Apameh Tarazi, Richard Wennberg
Pilomotor seizures are strongly associated with autoimmune encephalitis (AE), particularly anti-LGI1 encephalitis. The carbonic anhydrase inhibitor acetazolamide may have special efficacy for treating AE-associated pilomotor seizures. Six patients with AE (five anti-LGI1, one seronegative) and temporal lobe pilomotor seizures (five with seizures inducible by hyperventilation) were treated with acetazolamide, administered in a cycling (2-days-ON, 4-days-OFF) regimen to offset tolerance. Seizures were assessed during epilepsy monitoring unit (EMU) recordings in four inpatients (one of whom also maintained an outpatient seizure diary chronicling 1203 seizures over 1079 days); two outpatients self-reported seizure frequencies...
March 27, 2024: Epilepsia
https://read.qxmd.com/read/38528770/yield-and-utility-of-routine-epilepsy-panel-genetic-testing-among-young-patients-with-seizures
#18
JOURNAL ARTICLE
Emily Grew, Mayuri Reddy, Hayley Reichner, Jinsoo Kim, Misbah Salam, Anjum Hashim
Objective: We examined the yield of routine epilepsy panel genetic testing in pediatric patients. Methods: We retrospectively reviewed epilepsy genetic panel results routinely performed in the hospital or clinic on patients <8 years old from July 2021 to July 2023. We evaluated demographics, family history, seizure type, severity, and frequency, development, tone and movement abnormalities, dysmorphism, and electroencephalography (EEG) or magnetic resonance imaging (MRI) results as predictors of results...
March 25, 2024: Journal of Child Neurology
https://read.qxmd.com/read/38523714/isoflurane-treatment-for-refractory-and-super-refractory-status-epilepticus-in-dogs
#19
JOURNAL ARTICLE
Eirini Sarpekidou, Georgios Polyzois, Virginia Papageorgiou, Ioannis Savvas, Zoe Polizopoulou, George Kazakos
INTRODUCTION: Resistant epileptic episodes, such as refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE), are neurological emergencies that require immediate medical treatment. Although inhalational anesthetics, such as isoflurane (ISO), have been proposed as a means of seizure control in dogs, there is currently a lack of both experimental and clinical studies on this subject. STUDY DESIGN: This is a retrospective clinical study. METHODS: Records of dogs that received ISO for the management of RSE and SRSE during their intensive care unit (ICU) hospitalization at the Companion Animal Clinic of the Aristotle University of Thessaloniki were included in the present study...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38514863/small-molecule-caspase-1-inhibitor-czl80-terminates-refractory-status-epilepticus-via-inhibition-of-glutamatergic-transmission
#20
JOURNAL ARTICLE
Fei Wang, Yu Wang, Qing-Yang Zhang, Ke-Yu Hu, Ying-Jie Song, Lin Yang, Fan Fei, Ceng-Lin Xu, Sun-Liang Cui, Ye-Ping Ruan, Yi Wang, Zhong Chen
Status epilepticus (SE), a serious and often life-threatening medical emergency, is characterized by abnormally prolonged seizures. It is not effectively managed by present first-line anti-seizure medications and could readily develop into drug resistance without timely treatment. In this study, we highlight the therapeutic potential of CZL80, a small molecule that inhibits caspase-1, in SE termination and its related mechanisms. We found that delayed treatment of diazepam (0.5 h) easily induces resistance in kainic acid (KA)-induced SE...
March 21, 2024: Acta Pharmacologica Sinica
keyword
keyword
109139
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.